Kilimanjaro Clinical Research Institute
9
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Clinical Breast Examination and Patient Navigation Intervention in Sub-Saharan Africa
Role: collaborator
The P-KIDs CARE Health Systems Intervention in Tanzania
Role: collaborator
Using Healthcare Financing and Digital Technology to Improve Hypertension Prevention and Control in Tanzania
Role: collaborator
Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial
Role: lead
Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic
Role: lead
The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
Role: collaborator
Cytosponge™ Feasibility Study in Tanzania
Role: collaborator
Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
Role: collaborator
The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Role: lead
All 9 trials loaded